Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Stauderman Kenneth A. | Chief Scientific Officer | CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA | /s/ John Dunn, Esq., Attorney-in-Fact | 2025-07-29 | 0001969388 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CALC | Common Stock | Sale | -$3.65K | -1K | -100% | $3.65 | 0 | Jul 25, 2025 | By Spouse | F1 |
transaction | CALC | Common Stock | Purchase | $3.96K | +1K | +8.37% | $3.96 | 12.9K | Jul 28, 2025 | Direct |
Id | Content |
---|---|
F1 | The sale of the common stock of CalciMedica, Inc. (the "Issuer") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs. |